Literature DB >> 15023301

Vaccination and atherosclerosis.

Xinghua Zhou1, Göran K Hansson.   

Abstract

Atherosclerosis is an inflammatory disease. Both innate and adaptive immunity are involved in lesion formation and development. A number of antigen candidates, such as oxidized low-density lipoprotein and heat shock protein, have been associated with the inflammation and immune reaction that is part of the atherosclerotic process. Because experimental models of some other inflammatory/autoimmune diseases can be improved by vaccination, it is of interest to investigate if vaccination can also be applied to prevent or retard atherosclerosis. Indeed, the modification of immune responses in animal models can greatly affect the development and progression of atherosclerosis. This review provides an overview of our current understanding of effects and proposed mechanisms of immunization on preventing atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023301     DOI: 10.1007/s11883-004-0105-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  96 in total

Review 1.  Inflammation and therapeutic vaccination in CNS diseases.

Authors:  Howard L Weiner; Dennis J Selkoe
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 2.  Atherosclerosis--an autoimmune disease due to an immune reaction against heat-shock protein 60.

Authors:  G Wick
Journal:  Herz       Date:  2000-03       Impact factor: 1.443

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis.

Authors:  M Mayr; B Metzler; S Kiechl; J Willeit; G Schett; Q Xu; G Wick
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

5.  Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque.

Authors:  M Thomas; Y Wong; D Thomas; M Ajaz; V Tsang; P J Gallagher; M E Ward
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

6.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Endogenous neutralizing antibodies against platelet-derived growth factor-aa inhibit atherogenesis in the cholesterol-fed rabbit.

Authors:  D J Lamb; T Y Avades; G A Ferns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

8.  Association of influenza vaccination and reduced risk of recurrent myocardial infarction.

Authors:  M Naghavi; Z Barlas; S Siadaty; S Naguib; M Madjid; W Casscells
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

9.  Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.

Authors:  B Föger; M Chase; M J Amar; B L Vaisman; R D Shamburek; B Paigen; J Fruchart-Najib; J A Paiz; C A Koch; R F Hoyt; H B Brewer; S Santamarina-Fojo
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  The macrophage scavenger receptor type A directs modified proteins to antigen presentation.

Authors:  A Nicoletti; G Caligiuri; I Törnberg; T Kodama; S Stemme; G K Hansson
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

View more
  1 in total

1.  Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Authors:  Edit Bodolay; Zoltan Prohászka; Gyorgy Paragh; Istvan Csipő; Gabor Nagy; Renata Laczik; Nora Demeter; Eva Zöld; Britt Nakken; Gyula Szegedi; Peter Szodoray
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.